(Q43109219)

English

Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?

scientific article published on 5 April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship? (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

0 references

cardiovascular disease

1 reference

based on heuristic

inferred from title

Abdul Rashid Qureshi

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Peter Stenvinkel

7

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

object named as

Peter Barany

4

0 references

6

object named as

Bengt Lindholm

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Olof Heimbürger

5

object named as

Olof Heimburger

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

3

object named as

Tetsu Miyamoto

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

1

object named as

Hannes Olauson

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

author name string

Tobias E Larsson

8

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

language of work or name

0 references

publication date

5 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

3033-3038

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

The parathyroid is a target organ for FGF23 in rats

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

Chronic kidney disease, hypovitaminosis D, and mortality in the United States

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

Relationship between circulating FGF23 and total body atherosclerosis in the community

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ191

21 January 2018

Identifiers

10.1093/NDT/GFQ191

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43109219&oldid=1739993460"